Skip to main content
Log in

Antineoplastics

Early onset pulmonary events, lack of efficacy and off label use: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Lee BJ, et al. Early-Onset Pulmonary Events with Combined Brigatinib and Afatinib Treatment of L858/cisT790M/cisC797S NSCLC: A Case Report. American Journal of Case Reports 23: e937209, 23 Sep 2022. Available from: URL: http://doi.org/10.12659/AJCR.937209

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1942, 34 (2023). https://doi.org/10.1007/s40278-023-32643-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32643-4

Navigation